{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T03:50:32Z","timestamp":1747194632950,"version":"3.40.5"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Autoimmune thyroid disease (AITD) has a complex pathogenesis and is associated with the development of autoimmunity against the thyroid. Graves\u2019 disease and Hashimoto\u2019s thyroiditis are the two main types of AITD, and they are characterized by thyrotoxicosis and hypothyroidism, respectively. Atypical hemolytic uremic syndrome (aHUS) is a rare disease, presenting with microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. aHUS is caused by dysregulation of the alternative complement pathway, and its co-existence with AITD is rare.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We report the case of a 12-year-old girl with recent onset thyrotoxicosis. She was first treated with propylthiouracil for 2\u2009months and then developed AITD presenting as abrupt-onset thrombocytopenia, acute kidney injury, and microangiopathic hemolytic anemia. Thyroid function tests favored hyperthyroidism, with increased free T4 and free T3 levels and a very low level of thyroid-stimulating hormone (TSH). We suspected aHUS, and the patient\u2019s condition responded dramatically to therapeutic plasma exchange (TPE) with disease remission. She experienced recurrent aHUS after subsequently receiving methimazole for 1\u2009month, and in the recurrent episode, her condition responded again to TPE and concomitant glucocorticoids. She achieved euthyroidism with thiamazole ointment treatment, without aHUS recurrence during the 6-month follow-up. Mycophenolate mofetil was administered to manage proteinuria after 3\u2009months of treatment with the steroid and angiotensin-converting enzyme inhibitor.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The coexistence of aHUS and AITD in this case is likely more than coincidence, because both are autoimmune in origin. aHUS is associated with a high mortality without appropriate therapy, and treatment with TPE and adjunct immunosuppressants can be helpful.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12887-020-02082-0","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T07:02:44Z","timestamp":1587106964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Atypical hemolytic uremic syndrome precipitated by thyrotoxicosis: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2596-9953","authenticated-orcid":false,"given":"Ling","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1095-1120","authenticated-orcid":false,"given":"Yue","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,17]]},"reference":[{"key":"2082_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ped.12274","volume":"56","author":"T Sawai","year":"2014","unstructured":"Sawai T, Nangaku M, Ashida A, Fujimaru R, Hataya H, Hidaka Y, et al. Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the joint committee of the Japanese Society of nephrology and the Japan pediatric society. Pediatr Int. 2014;56:1\u20135.","journal-title":"Pediatr Int"},{"key":"2082_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","volume":"115","author":"I Moore","year":"2010","unstructured":"Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood. 2010;115:379\u201387.","journal-title":"Blood"},{"key":"2082_CR3","first-page":"3611","volume":"18","author":"YH Dong","year":"2014","unstructured":"Dong YH, Fu DG. Autoimmune thyroid disease: mechanism, genetics and current knowledge. Eur Rev Med Pharmacol Sci. 2014;18:3611\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2082_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/jca.21210","volume":"27","author":"S Chhabra","year":"2012","unstructured":"Chhabra S, Tenorio G. Thrombotic thrombocytopenic purpura precipitated by thyrotoxicosis. J Clin Apher. 2012;27:265\u20136.","journal-title":"J Clin Apher"},{"key":"2082_CR5","first-page":"5747969","volume":"2018","author":"K Lhotta","year":"2018","unstructured":"Lhotta K, Zitt E, Sprenger-Mahr H, Loacker L, Becherer A. Treatment of concurrent thrombotic thrombocytopenic Purpura and Graves\u2019 disease: a report on two cases. Case Rep Endocrinol. 2018;2018:5747969.","journal-title":"Case Rep Endocrinol"},{"key":"2082_CR6","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.003","volume":"23","author":"F Bellante","year":"2014","unstructured":"Bellante F, Redondo Saez P, Springael C, Dethy S. Stroke in thrombotic thrombocytopenic purpura induced by thyrotoxicosis: a case report. J Stroke Cerebrovasc Dis. 2014;23:1744\u20136.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2082_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MAJ.0b013e31812e9735","volume":"334","author":"BT Chaar","year":"2007","unstructured":"Chaar BT, Kudva GC, Olsen TJ, Silverberg AB, Grossman BJ. Thrombotic thrombocytopenic purpura and graves disease. Am J Med Sci. 2007;334:133\u20135.","journal-title":"Am J Med Sci"},{"key":"2082_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-3148.2011.01092.x","volume":"21","author":"WL Zheng","year":"2011","unstructured":"Zheng WL, Zhang GS, Deng MY. Thrombotic thrombocytopenic purpura complicating graves disease: dramatic response to plasma exchange and infusion. Transfus Med. 2011;21:354\u20135.","journal-title":"Transfus Med"},{"key":"2082_CR9","doi-asserted-by":"publisher","first-page":"omx057","DOI":"10.1093\/omcr\/omx057","volume":"2017","author":"SD Chitnis","year":"2017","unstructured":"Chitnis SD, Mene-Afejuku TO, Aujla A, Shady A, Gil GS, Cativo EH, et al. Thrombotic thrombocytopenic purpura possibly triggered by Graves\u2019 disease. Oxf Med Case Reports. 2017;2017:omx057.","journal-title":"Oxf Med Case Reports"},{"key":"2082_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.molimm.2016.01.003","volume":"71","author":"N Szarvas","year":"2016","unstructured":"Szarvas N, Szilagyi A, Csuka D, Takacs B, Rusai K, Muller T, et al. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome. Mol Immunol. 2016;71:10\u201322.","journal-title":"Mol Immunol"},{"key":"2082_CR11","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","volume":"125","author":"R Cofiell","year":"2015","unstructured":"Cofiell R, Kukreja A, Bedard K, Yan Y, Mickle AP, Ogawa M, et al. Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS. Blood. 2015;125:3253\u201362.","journal-title":"Blood"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-02082-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-020-02082-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-020-02082-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T23:17:01Z","timestamp":1618615021000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-020-02082-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,17]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2082"],"URL":"https:\/\/doi.org\/10.1186\/s12887-020-02082-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"type":"electronic","value":"1471-2431"}],"subject":[],"published":{"date-parts":[[2020,4,17]]},"assertion":[{"value":"18 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of Shengjing Hospital of China Medical University (2018PS497K). All procedures in studies involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s parent\/guardian for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}